09:00 - 9:30 | Login
09:30 - 9:40 | Welcome & introduction
- Dr. Sandra Sapich, BIOPRO Baden-Württemberg and Agnès Legoll, BioValley France
9:40 - 10:10 | Keynote from BW
- Microbiome in Health and Disease: Gut microbes revolutionizing cancer medicine
Dr. Christoph Stein-Thoeringer
Deutsches Krebsforschungszentrum (DKFZ), Division of Microbiome and Cancer, Heidelberg
10:10 - 10:40 | Keynote from France
- From gut flora to the microbiome revolution: what do we know about this neglected organ and its importance for Human health
Hervé M. Blottière, PhD
French National Research Institute for Agricultural and Food Research (INRAE), Pathophysiology of Nutritional Adaptations (UMR 1280), Paris
10:45 - 11:15 | Session I
- Patient microbiota modulation by fecal transplantation
Prof. Dr. Florian Fricke
Universität Hohenheim, Microbiome and Applied Bioinformatics, Stuttgart
- Diversity Matters! MaaT Pharma’s Microbiome Ecosystem Therapies in Graft-vs-host-Disease and Oncology
Dr. Savita Bernal
MaaT Pharma, Lyon
11:20 - 11:30 | Coffee break
11:30 - 11:55 | Pitch session I
- Dr. Oliver Deusch
Computomics, Tübingen
- Dr. Stephanie Badel
Biofilm Control, Saint Beauzire
- Prof. Dr. David Schleheck
University of Konstanz, Konstanz
- Dr. Romain Daillere
EverImmune, Villejuif
- Dr. Sylvie Maubant
Oncodesign, Dijon Cedex
11:55 - 12:40 | Session II
- Exploring the human microbiome from a genomic perspective
Dr. Robert Finn
EMBL-EBI, Cambridge
- Harnessing the Power of Gut Keystone Bacteria into Ground-Breaking Biotherapies
Georges Rawadi, PhD
Ysopia Bioscience, Bordeaux
- Assessing beneficial effects of probiotics in small animal models: ETAP-Lab’s experience
Jean-François Bisson, PhD
EtapLab, Vandoeuvre Les Nancy
12:40 - 12:50 | Coffee break
12:50 - 13:15 | Pitch session II
- Dr. Andrew Clark
University of Stuttgart, Stuttgart
- Dr. Tania Sorg
Phenomin, Illkirch-Graffenstaden
- Clarisse Meneghel
Smaltis, Besançon
- Dr. Vladimir Jakovjevic
Microbiome Power, Heidelberg
13:15 - 14:00 | Closing remarks & networking
14:00 | End of event